lomaira

Generic: phentermine hydrochloride

Labeler: calvin scott & co., inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name lomaira
Generic Name phentermine hydrochloride
Labeler calvin scott & co., inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

phentermine hydrochloride 8 mg/1

Manufacturer
Calvin Scott & Co., Inc.

Identifiers & Regulatory

Product NDC 17224-840
Product ID 17224-840_3a71a481-2240-1de3-e063-6294a90aaf19
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203495
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2016-09-12

Pharmacologic Class

Classes
appetite suppression [pe] increased sympathetic activity [pe] sympathomimetic amine anorectic [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 17224840
Hyphenated Format 17224-840

Supplemental Identifiers

RxCUI
826919 1810304
UNII
0K2I505OTV

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lomaira (source: ndc)
Generic Name phentermine hydrochloride (source: ndc)
Application Number ANDA203495 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 8 mg/1
source: ndc
Packaging
  • 28 TABLET in 1 BOTTLE (17224-840-28)
  • 30 TABLET in 1 BOTTLE (17224-840-30)
  • 60 TABLET in 1 BOTTLE (17224-840-60)
  • 90 TABLET in 1 BOTTLE (17224-840-90)
source: ndc

Packages (4)

Ingredients (1)

phentermine hydrochloride (8 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3a71a481-2240-1de3-e063-6294a90aaf19", "openfda": {"unii": ["0K2I505OTV"], "rxcui": ["826919", "1810304"], "spl_set_id": ["0718f0f3-77f2-45d7-be12-1ed718c8b806"], "manufacturer_name": ["Calvin Scott & Co., Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "28 TABLET in 1 BOTTLE (17224-840-28)", "package_ndc": "17224-840-28", "marketing_start_date": "20160912"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (17224-840-30)", "package_ndc": "17224-840-30", "marketing_start_date": "20160912"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (17224-840-60)", "package_ndc": "17224-840-60", "marketing_start_date": "20160912"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (17224-840-90)", "package_ndc": "17224-840-90", "marketing_start_date": "20160912"}], "brand_name": "LOMAIRA", "product_id": "17224-840_3a71a481-2240-1de3-e063-6294a90aaf19", "dosage_form": "TABLET", "pharm_class": ["Appetite Suppression [PE]", "Increased Sympathetic Activity [PE]", "Sympathomimetic Amine Anorectic [EPC]"], "product_ndc": "17224-840", "dea_schedule": "CIV", "generic_name": "PHENTERMINE HYDROCHLORIDE", "labeler_name": "Calvin Scott & Co., Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LOMAIRA", "active_ingredients": [{"name": "PHENTERMINE HYDROCHLORIDE", "strength": "8 mg/1"}], "application_number": "ANDA203495", "marketing_category": "ANDA", "marketing_start_date": "20160912", "listing_expiration_date": "20261231"}